You are viewing the site in preview mode

Skip to main content


Figure 1 | BMC Infectious Diseases

Figure 1

From: Balance of IL-10 and Interferon-γ plasma levels in human visceral leishmaniasis: Implications in the pathogenesis

Figure 1

Clinical and immunological parameters from acute VL at different periods after treatment. Spleen (A) liver (B) size and plasma IgG levels and their subclasses (C) from VL patients during acute VL (day 0) and at different periods after treatment (30, 120 and 210 days) are shown. Stimulation index obtained in proliferation assay from PBMC from VL stimulated with Leishmania antigen (10 μg/ml) are represented in D.

Back to article page